Skip to main content
鹿得医疗 logo

鹿得医疗 — Investor Relations & Filings

Ticker · 920278 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2022-12-18 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920278

About 鹿得医疗

https://www.asian-medical.com/

Jiangsu Lude Medical Device Co., Ltd. specializes in the research, development, and manufacturing of home medical diagnostic and respiratory care equipment. The company's core product portfolio includes mechanical and electronic sphygmomanometers, stethoscopes, nebulizers, and digital thermometers. It focuses on providing high-precision instruments for chronic disease management and home healthcare. With a strong emphasis on technical innovation and quality control, the firm maintains various international quality certifications to support its global OEM and ODM service capabilities. Its products are designed to meet the needs of both professional medical environments and domestic health monitoring, emphasizing accuracy, reliability, and user-friendly operation in the field of physiological parameter measurement.

Recent filings

Filing Released Lang Actions
关于预计2023年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected related party transactions for the year 2023. It includes details about the nature of transactions, amounts, related parties, board approval, and independent director opinions. The document is a formal disclosure of anticipated related party dealings, not a full financial report or audit. It is a regulatory announcement about related party transactions, which fits best under Regulatory Filings (RNS) as it does not contain comprehensive financial statements or detailed financial analysis. The document length is under 5,000 characters and is an announcement rather than a full report.
2022-12-18 Chinese
关于接待机构投资者调研情况的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the reception of institutional investor research on November 18, 2022. It includes a Q&A summary of the investor inquiries and company responses about business operations, stock repurchase progress, sales channels, cooperation with research institutes, and future performance outlook. There are no financial statements, earnings highlights, or detailed financial data presented. The document is relatively short (1610 characters) and serves as a communication of investor relations activity rather than a formal financial report or earnings release. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor engagement and company responses without substantive financial data or formal report content.
2022-11-21 Chinese
关于公司获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of an invention patent certificate. It details the patent name, patent number, and the impact of the patent on the company. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no management changes, no voting results, no legal proceedings, no capital changes, and no other financial or governance report content. The document is a regulatory announcement about intellectual property rights, which does not fit into financial report categories like Annual Report, Interim Report, Earnings Release, or others. It is a general regulatory announcement about a company event. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2022-11-14 Chinese
2022年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2022 Third Quarter Report" of Jiangsu Lude Medical Electronics Co., Ltd., covering the period from July 1, 2022 to September 30, 2022. It contains detailed financial data including balance sheets, profit and loss explanations, cash flow statements, and notes on significant changes in financial items. The document is about 15,000 characters long, which is substantial and contains actual financial statements and analysis for a quarterly period. It explicitly states it is a quarterly report and includes unaudited financial statements for the third quarter of 2022. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2022
2022-10-27 Chinese
第三届监事会第十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Jiangsu Lude Medical Electronics Co., Ltd. It details the meeting date, attendance, and resolutions passed, including approval of the company's 2022 third quarter report and a profit distribution proposal by a wholly-owned subsidiary. The document references the third quarter report and profit distribution announcements published separately on the Beijing Stock Exchange website, indicating this document itself is not the report but a meeting resolution announcement. The document length is short (1160 characters) and it does not contain actual financial statements or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a formal announcement of meeting resolutions and related approvals, not the financial report itself or a voting result announcement.
2022-10-27 Chinese
第三届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 14th meeting of the 3rd Board of Directors of Jiangsu Lude Medical Electronics Co., Ltd. It details the meeting date, attendance, and voting results on specific agenda items, including approval of the company's 2022 Q3 report and profit distribution of a wholly-owned subsidiary. The document does not contain the actual financial report or detailed financial data but references the 2022 Q3 report published elsewhere. It is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1229 characters), and it is not the report itself but an announcement of board decisions.
2022-10-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.